Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone in Hidradenitis Suppurativa
NCT04100083Phase 4Withdrawn
- Sponsor
- Medical University of South Carolina
- Start
- Sep 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of spironolactone in hidradenitis suppurativa (HS), sponsored by Medical University of South Carolina. Planned start Sep 2020; status: withdrawn.
02
Drugs
spironolactone
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on NCT04100083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04100083.